Abstract
In general practice, three patterns of hypertensive disease require special consideration: mild hypertension, hypertension in the elderly, and hypertensive patients with additional cardiovascular risk factors. The success of treatment must be balanced against its cost, which includes impaired quality of life. The aim should be to save lives without compromising lifestyles.
Hypercholesterolemia is more often found in hypertensive than in normotensive patients. A diagnostic workup of the lipid status and, if hyperlipidemia is diagnosed, its aggressive treatment are as important as the treatment of hypertension itself. Recent evidence shows that smoking has a negative effect on cardiovascular complications of hypertension and can entirely eliminate potential beneficial effects of some forms of antihypertensive treatment.
Keywords: cardiovascular disease, hypertension, pharmaceutic therapy
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bühler F. R., Kiowski W. Calcium antagonists in hypertension. J Hypertens Suppl. 1987 Aug;5(3):S3–10. [PubMed] [Google Scholar]
- Canner P. L., Berge K. G., Wenger N. K., Stamler J., Friedman L., Prineas R. J., Friedewald W. Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin. J Am Coll Cardiol. 1986 Dec;8(6):1245–1255. doi: 10.1016/s0735-1097(86)80293-5. [DOI] [PubMed] [Google Scholar]
- Coope J., Warrender T. S. Randomised trial of treatment of hypertension in elderly patients in primary care. Br Med J (Clin Res Ed) 1986 Nov 1;293(6555):1145–1151. doi: 10.1136/bmj.293.6555.1145. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Frick M. H., Elo O., Haapa K., Heinonen O. P., Heinsalmi P., Helo P., Huttunen J. K., Kaitaniemi P., Koskinen P., Manninen V. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med. 1987 Nov 12;317(20):1237–1245. doi: 10.1056/NEJM198711123172001. [DOI] [PubMed] [Google Scholar]
- Hjermann I., Holme I., Leren P. Oslo Study Diet and Antismoking Trial. Results after 102 months. Am J Med. 1986 Feb 14;80(2A):7–11. doi: 10.1016/0002-9343(86)90154-3. [DOI] [PubMed] [Google Scholar]
- Larochelle P., Bass M. J., Birkett N. J., De Champlain J., Myers M. G. Recommendations from the Consensus Conference on Hypertension in the Elderly. CMAJ. 1986 Oct 1;135(7):741–745. [PMC free article] [PubMed] [Google Scholar]
- Logan A. G. Report of the Canadian Hypertension Society's consensus conference on the management of mild hypertension. Can Med Assoc J. 1984 Nov 1;131(9):1053–1057. [PMC free article] [PubMed] [Google Scholar]
- MacMahon S. W., Macdonald G. J., Blacket R. B. Plasma lipoprotein levels in treated and untreated hypertensive men and women. The National Heart Foundation of Australia Risk Factor Prevalence Study. Arteriosclerosis. 1985 Jul-Aug;5(4):391–396. doi: 10.1161/01.atv.5.4.391. [DOI] [PubMed] [Google Scholar]
- Mattila K., Haavisto M., Rajala S., Heikinheimo R. Blood pressure and five year survival in the very old. Br Med J (Clin Res Ed) 1988 Mar 26;296(6626):887–889. doi: 10.1136/bmj.296.6626.887. [DOI] [PMC free article] [PubMed] [Google Scholar]